Loading clinical trials...
Loading clinical trials...
To assess the efficacy and safety of the administration of aflibercept by intravitreal injection in comparison to sham to control intraocular pressure in patients with neovascular glaucoma.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
Collaborators
NCT03187418 · Glaucoma, Glaucoma, Open-Angle, and more
NCT01922154 · Glaucoma, Neovascular
NCT04215575 · Glaucoma, Open-Angle, Glaucoma Secondary, and more
NCT01908816 · Choroidal Neovascularization, Macular Edema, and more
NCT02647515 · Diabetic Retinopathy, Glaucoma, Neovascular
Yoshida, Fukui
Gifu, Gifu
Amagasaki, Hyōgo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions